In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAF V600E mutation status and together with hypoxia-related proteins predicts aggressive behavior

Tumor tissue inhibitor of metalloproteinases-1 (TIMP-1) in hormone-independent breast cancer might originate in stromal cells, and improves stratification of prognosis together with nodal status

(2012) P. Kuvaja et al.   EXPERIMENTAL CELL RESEARCH

Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior

(2012) Sofia Asioli et al.   HUMAN PATHOLOGY

Targeting NF-κB and HIF-1 Pathways for the Treatment of Cancer: Part II

(2011) Jacek Wilczynski et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10

(2011) Florian Schelter et al.   CLINICAL & EXPERIMENTAL METASTASIS

BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy

(2011) Alessandra Bommarito et al.   ENDOCRINE-RELATED CANCER

High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer

(2010) M İlie et al.   BRITISH JOURNAL OF CANCER

Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α

(2010) Florian Schelter et al.   CLINICAL & EXPERIMENTAL METASTASIS

Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis

(2010) X. Lu et al.   CLINICAL CANCER RESEARCH

Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis

(2010) Marius I. Ilie et al.   INTERNATIONAL JOURNAL OF CANCER

Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer

(2010) Johanna Chiche et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

pH control mechanisms of tumor survival and growth

(2010) Scott K. Parks et al.   JOURNAL OF CELLULAR PHYSIOLOGY

BRAF V600E mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer

(2010) Monica Zerilli et al.   MODERN PATHOLOGY

Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer

(2009) E Korkeila et al.   BRITISH JOURNAL OF CANCER

Expression of hypoxia-inducible factor 1α in thyroid carcinomas

(2009) N Burrows et al.   ENDOCRINE-RELATED CANCER

Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid Microcarcinoma

(2008) Xiaolong Lee et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status

(2008) P Hofman et al.   BRITISH JOURNAL OF CANCER

Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH

(2008) J. Chiche et al.   CANCER RESEARCH

BRAFV600EMutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study

(2008) Rossella Elisei et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

(2008) Rebecca E. Schweppe et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas

(2008) Joonas Haapasalo et al.   NEURO-ONCOLOGY

Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities

(2008) W. G. Stetler-Stevenson   Science Signaling

Papillary Thyroid Carcinoma Tall Cell Variant

(2008) Ronald Ghossein et al.   THYROID

Papillary thyroid carcinoma with distant metastases: Survival predictors and the importance of local control

(2007) Iwao Sugitani et al.   SURGERY